August 18, 2026
1 min read

Nestlé turns GLP-1 weight-loss drug boom into product opportunity

Nestlé is using AI to develop nutrition products addressing GLP-1 side effects like muscle loss and “Ozempic face,” its CTO tells Reuters

Leave a Reply

Your email address will not be published.

Previous Story

Nutrition a key ingredient for Vermont students heading back to school

Next Story

SUMMITS Partners with HYPHEN to Launch Autonomous Precision Nutrition

Previous Story

Nutrition a key ingredient for Vermont students heading back to school

Next Story

SUMMITS Partners with HYPHEN to Launch Autonomous Precision Nutrition

Latest from Blog

Kindergarten vaccine exemptions are climbing

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Are Doritos real food? Could advertising make you think they are?  Read
Go toTop